BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Mar 27, 2026; 18(3): 115767
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.115767
Table 1 Baseline characteristics of patients in the control and multi-disciplinary team groups, n (%)
Baseline characteristics
Control group (n = 122)
MDT group (n = 129)
P value
Age (years), mean ± SD55.2 ± 10.154.9 ± 9.80.723
Gender0.845
Male67 (55.0)68 (52.7)
Female55 (45.0)61 (47.3)
BMI (kg/m²), mean ± SD23.4 ± 3.123.6 ± 3.00.652
Duration of stoma (months), mean ± SD8.5 ± 2.68.4 ± 2.50.876
Type of stoma0.789
Ileostomy72 (58.9)75 (58.1)
Colostomy50 (41.1)54 (41.9)
Previous surgery count, mean ± SD1.2 ± 0.41.3 ± 0.50.462
Chronic conditions0.521
DM17 (13.9)16 (12.4)
HTN15 (12.3)15 (11.6)
Asthma11 (9.0)13 (10.1)
CKD9 (7.4)8 (6.2)
Heart disease7 (5.7)8 (6.2)0.371
Preoperative Gut Symptom Score, mean ± SD6.2 ± 1.56.3 ± 1.40.425
Psychological State Score, mean ± SD3.1 ± 0.83.0 ± 0.70.538
Gut microbiome diversity, mean ± SD3.5 ± 0.63.6 ± 0.5
Gut microbiome function, mean ± SD2.8 ± 0.72.9 ± 0.60.614
Table 2 Comparative analysis of gut microbiome operational taxonomic unit counts between groups
Gut microbiome characteristics
Control group (n = 122)
MDT group (n = 129)
P value
OTUs of Bacteroidetes1.2 × 108 ± 5.0 × 1071.4 × 108 ± 4.8 × 1070.001
OTUs of Firmicutes1.8 × 108 ± 6.3 × 1071.7 × 108 ± 5.9 × 1070.033
OTUs of Proteobacteria6.1 × 107 ± 4.1 × 1067.3 × 107 ± 3.7 × 106< 0.001
Table 3 Gastrointestinal symptoms and postoperative hospital stay in control and multi-disciplinary team groups, n (%)
Outcome measure
Control group (n = 122)
MDT group (n = 129)
P value
Number of patients reporting
Abdominal pain38 (31.1)20 (15.5)0.003
Bloating52 (42.6)30 (23.3)0.001
Diarrhea29 (23.8)12 (9.3)0.014
Constipation15 (12.3)5 (3.9)0.032
Postoperative hospital stay (days)
≤ 5 days45 (36.9)76 (58.9)0.002
> 5 days77 (63.1)53 (41.1)0.002
Table 4 Impact of the multi-disciplinary team approach on chronic condition management, n (%)
Chronic condition management
Control group (n = 122)
MDT group (n = 129)
P value
Medication reduction for DM10 (8.2)22 (17.1)0.011
Medication reduction for HTN12 (9.8)25 (19.4)0.019
Medication reduction for CKD7 (5.7)16 (12.4)0.027
Table 5 Nutritional status indicators between control and multi-disciplinary team groups
Nutritional status indicators
Control group (n = 122)
MDT group (n = 129)
P value
BMI change-1.2 ± 0.4-0.8 ± 0.30.009
Malnutrition prevalence27 (22.1)12 (9.3)0.016
Serum sodium (mmol/L)135 ± 3137 ± 20.012
Serum potassium (mmol/L)3.9 ± 0.44.1 ± 0.30.028
Serum calcium (mg/dL)8.7 ± 0.69.0 ± 0.50.031
Vitamin B12 (pg/mL)200 ± 40220 ± 350.036
Vitamin D (ng/mL)20 ± 525 ± 40.019
Daily caloric intake (kcal)1800 ± 2002000 ± 1500.026
Protein intake (g/day)60 ± 1065 ± 80.017
Fiber intake (g/day)20 ± 525 ± 40.024
Table 6 Intestinal permeability and quality of life in control and multi-disciplinary team groups, mean ± SD
Outcome measures
Control group (n = 122)
MDT group (n = 129)
P value
Intestinal permeability - lactulose/mannitol ratio0.12 ± 0.030.09 ± 0.020.015
Quality of life - physical functioning (SF-36)68.9 ± 8.477.5 ± 7.30.022
Quality of life - mental health (SF-36)62.1 ± 9.270.4 ± 8.60.031
Quality of life - social functioning (SF-36)73.2 ± 10.181.5 ± 9.40.029